More Than 200 Abstracts Evaluating Celgene (CELG) Products across a Range of Indications to Be Presented at the 51st American Society of Hematology Meeting
11/11/2009 9:18:33 AM
More...
|
Celgene (CELG) (JOBS) 3rd-Quarter Profit Rises on Cancer Drug Sales
10/22/2009 6:35:41 AM
More...
|
PTC Therapeutics, Inc. Announces Celgene (CELG) Exercised Option to Drug Discovery Collaboration
9/2/2009 11:37:40 AM
More...
|
Celgene (CELG) (JOBS) Cancer Drug May Be Less Harmful to Heart
8/6/2009 7:15:55 AM
More...
|
Acceleron Pharma and Celgene (CELG) Initiate Phase 2 Study of ACE-011 to Treat Chemotherapy-Induced Anemia
7/28/2009 9:20:03 AM
More...
|
Celgene (CELG) Release: National Institute for Clinical Excellence (NICE) Guidance Gives Clinicians Go-Ahead To Prescribe Revlimid(R) For Treatment Of Relapsed/Refractory Multiple Myeloma
6/18/2009 9:15:09 AM
More...
|
Celgene (CELG) Arthritis Drug Effective in Mid-Stage Study
6/16/2009 7:41:43 AM
More...
|
Celgene (CELG) Announces Share Repurchase Program
4/27/2009 9:25:47 AM
More...
|
Celgene (CELG) Catches Heat for Disclosure Practices
4/10/2009 7:08:36 AM
More...
|
Celgene (CELG) Posts 4th-Quarter Loss; Drug Sales Rise
1/29/2009 6:29:24 AM
More...
|
|